„We are Mary Jane“ arrives in Barcelona
How many initiatives were born on March 8, 2018! Millions of women took to the streets in a historic global general strike that was repeated again in 2019. Just one year ago, on International Women’s…
Iberian Peninsula express shipping
0€ Orders over 60€
*6€ orders under 59€
East, West, South Europe express shipping
0€ Orders over 150€
*18€ orders under 149€
North Europe express shipping
0€ Orders over 160€
*20€ orders under 159€
Ireland, Norway, UK normal shipping
0€ Orders over 60€
*6€ orders under 59€
Rest of the world normal shipping
0€ Orders over 180€
*25€ orders under 179€
Shipping costs can be confirmed in your shopping cart.
For additional shipping methods, please reach out through info@kannabia.com.
*Website protected by SSL.
**Not available in all regions.
*Your coupon will be sent via email.
*Should you have any question, comment or feedback, please do not hesitate to contact us.
This decision has been taken after a recommendation from the State Medical Marijuana Advisory Board and a subsequent review carried out by the Secretary of Health and Human Services, Rachel Levine.
„I did not make this decision lightly,“ she said in a statement. „For both conditions, medical marijuana is not a first-line treatment and should not replace traditional therapies, but should be used together with them, when recommended by a doctor.“
In total, in this state list there are already 21 serious diseases for which cannabis treatment is recommended. Some of them are terminal cancer, chronic pain, multiple sclerosis or inflammatory bowel disease. Since their brains are still developing the Secretary of Health and Human Services has made however clear that medical cannabis will not be used to treat anxiety disorders in children or teenagers.
A few days before Rachel Levine announced this decision, a summit focused on the possibilities of medical research on cannabis had been held. Representatives of eight Pennsylvania universities participated in this meeting. In addition, it was recently approved that cannabis producers associate with these educational centres for this purpose and thus make this study easier.
The protocol to access this program is very similar to that of other states. Patients go to their doctor and he/she prescribes medical cannabis with a prescription. It is time to request your marijuana card from the Health Centre. To prescribe cannabis, health professionals must have received a four-hour course on the plant certified by the state of Pennsylvania.
This program would not contemplate smoked cannabis, but in other formats such as pills, oils or tinctures. It seems that it would be tax-free products, which is good news for patient pockets. What happens to patients who want to grow their own plants? It seems that there is no point to talk about home cultivation, so there would be a risk of fines if a person is discovered with plantations in his garden.
Currently, anxiety disorder is the most common mental illness in the United States. According to data from the Anxiety and Depression Association of America, more than 18% of the population is affected each year by this condition. Given this data, we could say that there are almost 1.73 million people in Pennsylvania who could join this medical cannabis program.
If we talk about Tourette syndrome, we find that about 200,000 Americans suffer from this neurological disorder in its most serious form, according to data from the National Institutes of Health of the United States. This disease is characterised by repetitive involuntary movements and tics in the form of vocalisations.
For her part, Rachel Levine has been clear with the diagnosis of anxiety disorders and has stated that it would be best for people who suffer from it to seek the best advice and therapy to stabilise their disease. She also said that it seems that medicinal cannabis varieties lower in THC content and high in CBD seem to be the most suitable for treating anxiety. The reason is that tetrahydrocannabinol could cause more anxiety, being the psychoactive substance, and cannabidiol could moderate the effects of THC, although there is no scientific evidence to support this.
Dyskinetic and spastic movement disorders, glaucoma, HIV / AIDS, multiple sclerosis, neuropathies, neurodegenerative diseases, sickle cell anaemia, terminal diseases, opioid use disorder, Parkinson’s disease, severe chronic or intractable pain of neuropathic origin or chronic or intractable pain serious … These are just some of the 21 medical conditions that are already included in the state list for the use of medical cannabis in Pennsylvania.